perampanel: Clinical Trials

14 trials of perampanel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 5 terminated, 1 unknown, 1 withdrawn. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 7, Terminated 5, Unknown 1, Withdrawn 1

Follow perampanel: new trials by email Literature Review of perampanel trials Research Report on perampanel

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
Perampanel - Refractory Status Epilepticus
Phase 4TerminatedWayne State University12025-10-102025-10-14
A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures
Perampanel - Epilepsy
Phase 4CompletedEisai Korea Inc.1252022-10-192025-03-07
Fycompa in Catamenial Epilepsy
Fycompa, Fycompa with a boost - Catamenial Epilepsy
Phase 4TerminatedUniversity of Florida72022-03-092024-07-31
Perampanel Titration and Cognitive Effects
Perampanel 1 week titration, Perampanel 2 week titration, Perampanel 4mg - Epilepsy
Phase 4TerminatedKimford Jay Meador292021-10-202024-06-06
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Anticonvulsant Agent, Perampanel, Quality-of-Life Assessment - Intractable Epilepsy, Malignant Glioma
Phase 4TerminatedMayo Clinic42020-12-042023-06-22
Correlation of Serum Level of Perampanel (PER) Level to Cerebrospinal Fluid (CSF) Levels of PER
Perampanel - Epilepsy, Seizures
Phase 4UnknownCarilion Clinic252019-11-012021-09-16
Effects of Perampanel on Neurophysiology Test Perimeters
Perampanel 6 MG - Healthy
Phase 4CompletedWeill Medical College of Cornell University122018-10-012023-07-03
Fycompa Titration Intervals and Effects on Retention Rate
Perampanel Oral Tablet - Epilepsy
Phase 4CompletedUniversity of Arizona202018-04-182023-08-15
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Perampanel - Partial Onset Seizures, Secondarily Generalized Seizures
Phase 4CompletedEisai Inc.542017-08-232022-05-16
Effects of Perampanel on Cognition and Electroencephalography in Patients With Epilepsy
Perampanel - Electroencephalography
Phase 4CompletedSeoul National University Hospital302016-12-012021-09-29
Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization
Perampanel - Epilepsy
Phase 4CompletedEisai Korea Inc.1062016-05-032020-02-05
Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
perampanel - Epilepsy
Phase 4TerminatedMid-Atlantic Epilepsy and Sleep Center, LLC82015-11-012017-08-29
Perampanel in Seizure Patients With Primary Glial Brain Tumors
Perampanel - Brain Tumor, Primary
Phase 4CompletedDuke University92015-04-072018-04-27
To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures
Perampanel, Placebo - Epilepsy, Partial
Phase 4WithdrawnEisai Inc.2015-03-012015-02-10

Conditions studied

Epilepsy (9)  ·  Seizures (4)  ·  Epilepsies, Partial (2)  ·  Brain Neoplasms (1)  ·  Drug Resistant Epilepsy (1)  ·  Glioma (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Status Epilepticus (1)

Sponsors

Eisai Inc. (2)  ·  Eisai Korea Inc. (2)  ·  Carilion Clinic (1)  ·  Duke University (1)  ·  Kimford Jay Meador (1)  ·  Mayo Clinic (1)  ·  Mid-Atlantic Epilepsy and Sleep Center, LLC (1)  ·  Seoul National University Hospital (1)  ·  University of Arizona (1)  ·  University of Florida (1)  ·  Wayne State University (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (10)  ·  South Korea (3)

Top investigators

Aashit Shah, MD (1)  ·  David Chuang, M.D. (1)  ·  Katherine B Peters, MD, PhD (1)  ·  Katherine Zarroli, MD (1)  ·  Ki-Young Jung, M.D, Ph.D (1)  ·  Kimford Meador, MD (1)  ·  Maysaa Basha, MD (1)  ·  Norman C Wang, MD (1)  ·  Pavel Klein, M.B,B.Chir. (1)  ·  Wazim Mohamed, MD (1)  ·  William Tatum (1)

NIH funding

2017 (1)